Modifiable and non-modifiable factors associated with functional impairment during the inter-episodic periods of bipolar disorder

European Archives of Psychiatry and Clinical Neuroscience

Volumn 268, Issue 8, 2018, Pages 749-755

  Murru, Andrea ^a   Pacchiarotti, Isabella ^a   Verdolini, Norma ^a,b   Reinares, Maria ^a   Torrent, Carla ^a   Geoffroy, Pierre Alexis ^c,d,e,f   Bellivier, Frank ^c,d,e,f   Llorca, Pierre Michel ^f,g   Vieta, Eduard ^a   Samalin, Ludovic ^f,g  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF PERUGIA   (Italy)

^c UMR S 1144   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^f FONDATION FONDAMENTAL   (France)

^g UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

Bipolar disorder; Functioning; Inter episodic periods; Predominant polarity; Residual symptoms

Indexed keywords

ADULT; AGE; ARTICLE; BIPOLAR DEPRESSION RATING SCALE; BIPOLAR DISORDER; BIPOLAR MANIA; CLINICAL GLOBAL IMPRESSION SCALE; COGNITION; COMORBIDITY; CROSS-SECTIONAL STUDY; DEPRESSION ASSESSMENT; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FUNCTIONAL DISEASE; GENDER; HUMAN; HUMAN RELATION; LEISURE; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; MIDDLE AGED; PRIORITY JOURNAL; PSYCHIATRIST; SOCIAL PSYCHOLOGY; WORK CAPACITY; YOUNG MANIA RATING SCALE; ADOLESCENT; CLINICAL TRIAL; MULTICENTER STUDY; PATHOPHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; SOCIOECONOMICS; STATISTICAL MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; BIPOLAR DISORDER; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 85019851713     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-017-0811-0     Document Type: Article

References (43)

1. Kraepelin E (1920) Die Erscheinungsformen des Irreseins. Z Gesamte Neurol Psychiatr 62(1):29
2. Trede K, Salvatore P, Baethge C et al (2005) Manic-depressive illness: evolution in Kraepelin’s Textbook, 1883–1926. Harv Rev Psychiatry 13:155–178. doi:10.1080/10,673,220,500,174,833
3. Bonnín CM, Martínez-Arán A, Torrent C et al (2010) Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: a long-term, follow-up study. J Affect Disord 121:156–160. doi:10.1016/j.jad.2009.05.014
4. De Dios C, Ezquiaga E, Agud JL et al (2012) Subthreshold symptoms and time to relapse/recurrence in a community cohort of bipolar disorder outpatients. J Affect Disord 143:160–165. doi:10.1016/j.jad.2012.05.047
5. Martínez-Arán A, Vieta E, Colom F et al (2004) Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. Bipolar Disord 6:224–232. doi:10.1111/j.1399-5618.2004.00111.x
6. Goldberg JF, Harrow M, Grossman LS (1995) Course and outcome in bipolar affective disorder: a longitudinal follow-up study. Am J Psychiatry 152:379–384. doi:10.1176/ajp.152.3.379
7. Tohen M, Hennen J, Zarate CM et al (2000) Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry 157:220–228. doi:10.1176/appi.ajp.157.2.220
8. Samalin L, Murru A, Vieta E (2016) Management of inter-episodic periods in patients with bipolar disorder. Expert Rev Neurother. doi:10.1080/14737175.2016.1176530
9. Rosa AR, Magalhães PVS, Czepielewski L et al (2014) Clinical staging in bipolar disorder. J Clin Psychiatry 75:e450–e456. doi:10.4088/JCP.13m08625
10. Avila CC, Cabello M, Cieza A et al (2010) Functioning and disability in bipolar disorders: a systematic review of literature using the ICF as a reference. Bipolar Disord 12:473–482. doi:10.1111/j.1399-5618.2010.00833.x
11. Samalin L, Llorca P, Giordana B et al (2014) Residual symptoms and functional performance in a large sample of euthymic bipolar patients in France (the OPTHYMUM study). J Affect Disord. doi:10.1016/j.jad.2014.02.023
12. Samalin L, de Chazeron I, Vieta E et al (2016) Residual symptoms and specific functional impairments in euthymic patients with bipolar disorder. Bipolar Disord 18:164–173. doi:10.1111/bdi.12376
13. Rosa AR, Sánchez-Moreno J, Martínez-Aran A et al (2007) Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health 3:5. doi:10.1186/1745-0179-3-5
14. American Psychiatric Association (2000) DSM-IV-TR: diagnostic and statistical manual of mental disorders, IV edition
15. Tohen M, Frank E, Bowden CL et al (2009) The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord 11:453–473. doi:10.1111/j.1399-5618.2009.00726.x
16. Young RC, Biggs JT, Ziegler VE, Meyer DA (1978) A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429–435
17. Berk M, Malhi GS, Cahill C et al (2007) The Bipolar Depression Rating Scale (BDRS): its development, validation and utility. Bipolar Disord 9:571–579. doi:10.1111/j.1399-5618.2007.00536.x
18. Colom F, Vieta E, Daban C et al (2006) Clinical and therapeutic implications of predominant polarity in bipolar disorder. J Affect Disord 93:13–17. doi:10.1016/j.jad.2006.01.032
19. Spearing M, Post M, Leverich G et al (1997) Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 73:159–171
20. Pallaskorpi S, Suominen K, Ketokivi M et al (2015) Five-year outcome of bipolar I and II disorders: findings of the Jorvi Bipolar Study. Bipolar Disord 17:363–374. doi:10.1111/bdi.12291
21. Solé B, Jiménez E, Torrent C et al (2016) Cognitive variability in bipolar II disorder: who is cognitively impaired and who is preserved. Bipolar Disord 18:288–299. doi:10.1111/bdi.12385
22. López-Jaramillo C, Lopera-Vásquez J, Gallo A et al (2010) Effects of recurrence on the cognitive performance of patients with bipolar I disorder: implications for relapse prevention and treatment adherence. Bipolar Disord 12:557–567. doi:10.1111/j.1399-5618.2010.00835.x
23. Colom F, Vieta E, Suppes T (2015) Predominant polarity in bipolar disorders: refining or redefining diagnosis? Acta Psychiatr Scand 132:324–326. doi:10.1111/acps.12503
24. Rosa AR, Andreazza AC, Kunz M et al (2008) Predominant polarity in bipolar disorder: diagnostic implications. J Affect Disord 107:45–51. doi:10.1016/j.jad.2007.07.021
25. Murru A, Pacchiarotti I, Amann BL et al (2013) Treatment adherence in bipolar i and schizoaffective disorder, bipolar type. J Affect Disord 151:1003–1008
26. Nivoli AM, Colom F, Pacchiarotti I et al (2013) Treatment strategies according to clinical features in a naturalistic cohort study of bipolar patients: a principal component analysis of lifetime pharmacological and biophysic treatment options. Eur Neuropsychopharmacol 23:263–275
27. Colom F, Vieta E, Sánchez-Moreno J et al (2009) Group psychoeducation for stabilised bipolar disorders: 5-year outcome of a randomised clinical trial. Br J Psychiatry 194:260–265. doi:10.1192/bjp.bp.107.040485
28. Reinares M, Colom F, Sánchez-Moreno J et al (2008) Impact of caregiver group psychoeducation on the course and outcome of bipolar patients in remission: a randomized controlled trial. Bipolar Disord 10:511–519. doi:10.1111/j.1399-5618.2008.00588.x
29. Popovic D, Reinares M, Goikolea JM et al (2012) Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder. Eur Neuropsychopharmacol 22:339–346. doi:10.1016/j.euroneuro.2011.09.008
30. Reinares M, Papachristou E, Harvey P et al (2013) Towards a clinical staging for bipolar disorder: defining patient subtypes based on functional outcome. J Affect Disord 144:65–71. doi:10.1016/j.jad.2012.06.005
31. Bonnín CM, Sánchez-Moreno J, Martínez-Arán A et al (2012) Subthreshold symptoms in bipolar disorder: impact on neurocognition, quality of life and disability. J Affect Disord 136:650–659. doi:10.1016/j.jad.2011.10.012
32. Fountoulakis KN, Vieta E, Young A et al (2016) The International College of Neuropsychopharmacology (CINP) treatment guidelines for bipolar disorder in adults (CINP-BD-2017), part 4: unmet needs in the treatment of bipolar disorder and recommendations for future research. Int J Neuropsychopharmacol. doi:10.1093/ijnp/pyw072
33. Kapczinski F, Dias VV, Kauer-Sant’Anna M et al (2009) Clinical implications of a staging model for bipolar disorders. Expert Rev Neurother 9:957–966. doi:10.1586/ern.09.31
34. Berk M, Hallam KT, McGorry PD (2007) The potential utility of a staging model as a course specifier: a bipolar disorder perspective. J Affect Disord 100:279–281. doi:10.1016/j.jad.2007.03.007
35. Alda M, Kapczinski F (2016) Staging model raises fundamental questions about the nature of bipolar disorder. J Psychiatry Neurosci 41:291–293. doi:10.1503/jpn.160151
36. Vieta E, Popovic D, Rosa AR et al (2013) The clinical implications of cognitive impairment and allostatic load in bipolar disorder. Eur Psychiatry 28:21–29. doi:10.1016/j.eurpsy.2011.11.007
37. Schumann G, Binder EB, Holte A et al (2014) Stratified medicine for mental disorders. Eur Neuropsychopharmacol 24:5–50. doi:10.1016/j.euroneuro.2013.09.010
38. Murru A, Primavera D, Oliva M et al (2015) The role of comorbidities in duration of untreated illness for bipolar spectrum disorders. J Affect Disord 188:319–323. doi:10.1016/j.jad.2015.09.009
39. Fountoulakis KN, Young A, Yatham L et al (2016) The International College of Neuropsychopharmacology (CINP) treatment guidelines for bipolar disorder in adults (CINP-BD-2017), part 1: background and methods of the development of guidelines. Int J Neuropsychopharmacol. doi:10.1093/ijnp/pyw091
40. Carvalho AF, Quevedo J, McIntyre RS et al (2014) Treatment implications of predominant polarity and the polarity index: a comprehensive review. Int J Neuropsychopharmacol. doi:10.1093/ijnp/pyu079
41. Martinez-Aran A, Vieta E, Torrent C et al (2007) Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord 9:103–113. doi:10.1111/j.1399-5618.2007.00327.x
42. Kanady JC, Soehner AM, Klein AB, Harvey AG (2017) The association between insomnia-related sleep disruptions and cognitive dysfunction during the inter-episode phase of bipolar disorder. J Psychiatr Res 88:80–88. doi:10.1016/j.jpsychires.2017.01.001
43. Torrent C, Martinez-Arán A, del Mar Bonnin C et al (2012) Long-term outcome of cognitive impairment in bipolar disorder. J Clin Psychiatry 73:e899–e905. doi:10.4088/JCP.11m07471